LDXHF Financials: Lumos Diagnostics Holdings Limited AI Analysis



Financials

LDXHF Financial

Lumos Diagnostics Holdings Limited

$0.07

At close: Jun 12, 16:00:00 GMT-4

$0.07

Post-market: Jun 12, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.07

Open

$0.08

Day's Range

$0.07 - $0.08

52 week range

$0.0161 - $0.24

Volume

10.0K

Avg.Volume

68.6K

Dividend yield

EPS (TTM)

-0.01

Market Cap

$64.6M

What is LUMOS DIAGNOSTICS HLDGS LTD?

Lumos Diagnostics Holdings Ltd. engages in the development and manufacture of point-of-care diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions. The firm offers customized assay development and manufacturing services for POC tests and digital reader platforms. The company also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a rapid point-of-care diagnostic product that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. The company manages the full development program for POC assays.

Features

Markets

News

Breakdown	TTM	12/31/2025	06/30/2025	12/31/2024	06/30/2024	12/31/2023
Revenue	12	6	6	6	8	2
Revenue Growth (YoY)	-14%	0%	-25%	200%	60%	-60%
Cost of Revenue	4	1	2	2	2	1
Gross Profit	7	4	3	4	5	1
Selling, General & Admin	15	9	6	6	5	5
Research & Development	0	0	0	0	0	0
Operating Expenses	15	8	7	6	6	6
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-9	-4	-4	-2	-2	-6
Income Tax Expense	0	0	0	0	0	0
Net Income	-9	-4	-4	-2	-2	-6
Net Income Growth	125%	100%	100%	-67%	0%	0%
Shares Outstanding (Diluted)	772.43	772.43	747.4	612.95	513.63	473.67
Shares Change (YoY)	26%	26%	46%	28.99%	98%	126%
EPS (Diluted)	-0.01	0	0	0	0	-0.01
EPS Growth	39%	37%	40%	-66%	-57.99%	-55%
Free Cash Flow	-2	0	-3	-6	5	-4
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	58.33%	66.66%	50%	66.66%	62.5%	50%
Operating Margin	-66.66%	-66.66%	-50%	-33.33%	-12.5%	-250%
Profit Margin	-75%	-66.66%	-66.66%	-33.33%	-25%	-300%
Free Cash Flow Margin	-16.66%	0%	-50%	-100%	62.5%	-200%
EBITDA	-6	-3	-2	-1	0	-4
EBITDA Margin	-50%	-50%	-33.33%	-16.66%	0%	-200%
D&A For EBITDA	2	1	1	1	1	1
EBIT	-8	-4	-3	-2	-1	-5
EBIT Margin	-66.66%	-66.66%	-50%	-33.33%	-12.5%	-250%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Breakdown

TTM

12/31/2025

06/30/2025

12/31/2024

06/30/2024

12/31/2023

Revenue

Revenue Growth (YoY)

-14%

-25%

200%

60%

-60%

Cost of Revenue

Gross Profit

Selling, General & Admin

Research & Development

Operating Expenses

Other Non Operating Income (Expenses)

Pretax Income

-9

-4

-2

-6

Income Tax Expense

Net Income

-9

-4

-2

-6

Net Income Growth

125%

100%

-67%

Shares Outstanding (Diluted)

772.43

747.4

612.95

513.63

473.67

Shares Change (YoY)

26%

46%

28.99%

98%

126%

EPS (Diluted)

-0.01

EPS Growth

39%

37%

40%

-66%

-57.99%

-55%

Free Cash Flow

-2

-3

-6

-4

Free Cash Flow Per Share

Gross Margin

58.33%

66.66%

50%

66.66%

62.5%

50%

Operating Margin

-66.66%

-50%

-33.33%

-12.5%

-250%

Profit Margin

-75%

-66.66%

-33.33%

-25%

-300%

Free Cash Flow Margin

-16.66%

-50%

-100%

62.5%

-200%

EBITDA

-6

-3

-2

-1

-4

EBITDA Margin

-50%

-33.33%

-16.66%

-200%

D&A For EBITDA

EBIT

-8

-4

-3

-2

-1

-5

EBIT Margin

-66.66%

-50%

-33.33%

-12.5%

-250%

Effective Tax Rate

Follow-Up Questions

What are Lumos Diagnostics Holdings Limited's key financial statements?



According to the latest financial statement (Form-10K), Lumos Diagnostics Holdings Limited has a total asset of $0, Net loss of $0

What are the key financial ratios for LDXHF?



Lumos Diagnostics Holdings Limited's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Lumos Diagnostics Holdings Limited's revenue broken down by segment or geography?



Lumos Diagnostics Holdings Limited largest revenue segment is Services, at a revenue of 16,331,831 in the most earnings release.For geography, United States is the primary market for Lumos Diagnostics Holdings Limited, at a revenue of 19,146,706.

Is Lumos Diagnostics Holdings Limited profitable?



no, according to the latest financial statements, Lumos Diagnostics Holdings Limited has a net loss of $0

Does Lumos Diagnostics Holdings Limited have any liabilities?



no, Lumos Diagnostics Holdings Limited has liability of 0

How many outstanding shares for Lumos Diagnostics Holdings Limited?



Lumos Diagnostics Holdings Limited has a total outstanding shares of 0

Lumos Diagnostics Holdings Limited (LDXHF) Financial

LDXHF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is LUMOS DIAGNOSTICS HLDGS LTD?

Lumos Diagnostics Holdings Limited (LDXHF) Financial

LDXHF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is LUMOS DIAGNOSTICS HLDGS LTD?

LDXHF Income

Follow-Up Questions

What are Lumos Diagnostics Holdings Limited's key financial statements?

What are the key financial ratios for LDXHF?

How is Lumos Diagnostics Holdings Limited's revenue broken down by segment or geography?

Is Lumos Diagnostics Holdings Limited profitable?

Does Lumos Diagnostics Holdings Limited have any liabilities?

How many outstanding shares for Lumos Diagnostics Holdings Limited?